R. Hulhoven

618 total citations
38 papers, 472 citations indexed

About

R. Hulhoven is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, R. Hulhoven has authored 38 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in R. Hulhoven's work include Chronic Lymphocytic Leukemia Research (6 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer Treatment and Pharmacology (6 papers). R. Hulhoven is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer Treatment and Pharmacology (6 papers). R. Hulhoven collaborates with scholars based in Belgium, France and United States. R. Hulhoven's co-authors include J.P. Desager, C. Harvengt, Jean‐Pierre Desager, Armel Stockis, Dominique Rosillon, Michel Letiexhe, G. Sokal, William E. Bridson, Yves Horsmans and Shikiko Watanabe and has published in prestigious journals such as Journal of Chromatography A, Annals of the Rheumatic Diseases and Psychopharmacology.

In The Last Decade

R. Hulhoven

37 papers receiving 424 citations

Peers

Countries citing papers authored by R. Hulhoven

Since Specialization

Citations

This map shows the geographic impact of R. Hulhoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hulhoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hulhoven more than expected).

Fields of papers citing papers by R. Hulhoven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hulhoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hulhoven. The network helps show where R. Hulhoven may publish in the future.

Co-authorship network of co-authors of R. Hulhoven

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hulhoven. A scholar is included among the top collaborators of R. Hulhoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hulhoven. R. Hulhoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of levetiracetam on cardiac repolarization in healthy subjects: A single-dose, randomized, placebo- and active-controlled, four-way crossover study 2008 ·Clinical Therapeutics ·R. Hulhoven, Dominique Rosillon, William E. Bridson, (unknown), (unknown), Armel Stockis	38
2	Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study 2007 ·European Journal of Clinical Pharmacology ·R. Hulhoven, Dominique Rosillon, Michel Letiexhe, (unknown), (unknown), Armel Stockis	51
3	Levetiracetam and bleeding disorders. 2007 ·PubMed ·Paul Boon, R. Hulhoven, Fritz Offner	7
4	Levocetirizine in 1 2 year old children: pharmacokinetic and pharmacodynamic profile 2005 ·International Journal of Clinical Pharmacology and Therapeutics ·Noel Cranswick, (unknown), (unknown), R. Hulhoven	21
5	Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers* 1997 ·Clinical Pharmacology & Therapeutics ·V Špičák, (unknown), R. Hulhoven, Jean‐Pierre Desager, (unknown), M. de Longueville, (unknown)	23
6	Effect of 1‐280α‐h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation 1995 ·Clinical Transplantation ·Pierre Gianello, Marianne Carlier, Jacques Jamart, R. Hulhoven, J. Bernheim, Alfred Bernard, J M Ketelslegers, Jean Squifflet	8
7	LACK OF CLINICALLY RELEVANT INTERACTION OF CETIRIZINE ON THEOPHYLLINE DISPOSITION IN HEALTHY SUBJECTS 1995 ·American Journal of Therapeutics ·R. Hulhoven, J.P. Desager, C. Harvengt	4
8	Single‐Dose Pharmacokinetics of Cetirizine in Patients With Chronic Liver Disease 1993 ·The Journal of Clinical Pharmacology ·Yves Horsmans, J.P. Desager, R. Hulhoven, C. Harvengt	24
9	Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic 1988 ·Psychopharmacology ·J.P. Desager, R. Hulhoven, C. Harvengt, P Hermann, P Guillet, J. F. Thiercelin	17
10	Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjects 1988 ·European Journal of Clinical Pharmacology ·R. Hulhoven, J.P. Desager, S. Cox, C. Harvengt	4
11	Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects. 1985 ·PubMed ·Suzanne Pourbaix, Jean‐Pierre Desager, R. Hulhoven, (unknown), C. Harvengt	25
12	Disposition of Daunorubicin and Daunorubicin-dna Complex in Rabbits 1983 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·R. Hulhoven, C. Harvengt	1
13	HPLC determination of mitoxantrone in biological fluids: A sensitive and accurate method 1983 ·Journal of High Resolution Chromatography ·R. Hulhoven, J.P. Desager	7
14	Vindesine in Leukemia and Non-hodgkin Lymphoma 1982 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·G Mathé, R. Hulhoven	1
15	Distribution of Daunorubicin Intravenously Injected or Intravenously Infused as Free Drug and as a Complex with DNA in Rabbits 1982 ·Pharmacology ·R. Hulhoven, C. Harvengt	2
16	Human pharmacolinetics of the daunorubicin-DNA complex 1979 ·Cancer Chemotherapy and Pharmacology ·R. Hulhoven, G. Sokal, C. Harvengt	10
17	Daunorubicin, daunorubicinol and DNA plasma kinetics after I.V. administration of daunorubican-DNA complex in the rabbit. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·R. Hulhoven	7
18	Mesure Quantitative de L'Activité de la Desoxyribonuclease Plasmatique et de Son Inhibition Par le Complexe Daunorubicine‐ADN 1978 ·Bulletin des Sociétés Chimiques Belges ·R. Hulhoven, J.P. Desager, A. Zenebergh	3
19	HPLC determination of daunorubicin and daunorubicinol in human plasma. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·R. Hulhoven, (unknown)	13
20	Daunomycin and daunomycinol plasma levels measured by HPLC after perfusions of daunomycin and daunomycin-DNA complex in rabbits: a preliminary report. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·R. Hulhoven, (unknown), G. Sokal, C. Harvengt	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact